Icotyde gauges oral psoriasis demand
6 articles curated from biotech news
Icotyde may provide clearest test yet of demand for oral psoriasis drugs
BioCenturyMar 18, 2026With FDA Approval, Icotyde Wades Into Competitive Psoriasis Market
Citeline - ScripMar 18, 2026J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections
BioPharma DiveMar 18, 2026Icotyde’s in; wave of switchers to oral psoriasis Protagonist?
BioWorld (Clarivate)Mar 18, 2026FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential
Endpoints NewsMar 18, 2026J&J Wins FDA Nod for First Targeted Oral Anti-IL-23 Therapy for Plaque Psoriasis
BioSpaceMar 18, 2026
Want daily biotech news like this? Sign up free